TMEM16A controls EGF-induced calcium signaling implicated in pancreatic cancer prognosis

David Crottès, Yu-Hsiu T. Lin, Christian J. Peters, John M. Gilchrist, Arun P. Wiita, Yuh Nung Jan, Lily Yeh Jan

Proceedings of the National Academy of Sciences · 2019 · 77 citations · 36 references

DOIFull text

Open access

Concepts

Abstract

Pancreatic cancer typically spreads rapidly and has poor survival rates. Here, we report that the calcium-activated chloride channel TMEM16A is a biomarker for pancreatic cancer with a poor prognosis. TMEM16A is up-regulated in 75% of cases of pancreatic cancer and high levels of TMEM16A expression are correlated with low patient survival probability. TMEM16A up-regulation is associated with the ligand-dependent EGFR signaling pathway. In vitro, TMEM16A is required for EGF-induced store-operated calcium entry essential for pancreatic cancer cell migration. TMEM16A also has a profound impact on phosphoproteome remodeling upon EGF stimulation. Moreover, molecular actors identified in this TMEM16A-dependent EGFR-induced calcium signaling pathway form a gene set that makes it possible not only to distinguish neuro-endocrine tumors from other forms of pancreatic cancer, but also to subdivide the latter into three clusters with distinct genetic profiles that could reflect their molecular underpinning.

References

36